Karuna Therapeutics Inc (KRTX) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Karuna Therapeutics Inc   (NASDAQ: KRTX)


Karuna Therapeutics Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Karuna Therapeutics Inc's ROI in the fourth quarter of 2023?
Karuna Therapeutics Inc recorded a cumulative net loss of $-434 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -31.43%.

Within the Healthcare sector 468 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 3664 to 3904.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM 73.25 % 110.27 % 175.87 % 105.02 % 45.76 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,258 1,336 1,434 1,491 1,129
Return On Investment (TTM) -31.43 % -29.39 % -27.01 % -29.94 % -34.7 %
KRTX's Overall Ranking # 3904 # 3664 # 3685 # 2835 # 3988
Seq. Investment Change TTM 2.39 % 2.83 % 24.27 % 32.41 % 24.26 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -434 -396 -354 -316 -276

KRTX Company Profile >> Back to KRTX Roi Comparisons >> See Annual KRTX Return On Investment



Return On Investment KRTX's Ranking
Within: No.
Industry # 180
Sector # 469
Overall # 3904

Return On Investment Statistics
High Average Low
-12.95 %
-27.09 %
-42.54 %
(Jun 30 2020)   (Jun 30 2022)







Financial Statements
Karuna Therapeutics Inc's IV. Quarter Investments $ 1,258 Millions KRTX's Balance sheet
Karuna Therapeutics Inc's IV. Quarter Income $ -114 Millions Quarterly KRTX's Income Statement
KRTX's Income by Division See KRTX's Income by Division


KRTX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 1,258 1,129 507 341 390
Y / Y Investment Growth 11.39 % 122.56 % 48.91 % -12.64 % -
Net Income in Millions -434 -276 -144 -69 -44
Y / Y Net Income Growth - - - - -
Annual Return On Investment -34.47 % -24.47 % -28.34 % -20.12 % -11.27 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KRTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KRTX's Competitors
Subscribers only: Roi for Karuna Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for KRTX's Customers

Other Ratios
KRTX's Roa KRTX's Inventory Turnover Ratio KRTX's Growth Rates KRTX's Dividend Statistics
KRTX's Profitability Ratios KRTX's Asset Turnover Ratio KRTX's Dividend Growth
KRTX's Roe KRTX's Valuation Ratios KRTX's Financial Strength Ratios KRTX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.